News Conference News PCR London Valves 2024 Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE Michael O'Riordan December 03, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News TCT 2024 Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis Caitlin E. Cox November 08, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
News Conference News EACTS 2024 TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb Yael L. Maxwell October 21, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER Todd Neale August 31, 2024
News Conference News NY Valves 2024 T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies Todd Neale June 07, 2024
News Conference News NY Valves 2024 AV Block Common After Transcatheter Tricuspid Valve Replacement for TR Michael O'Riordan June 07, 2024
News Conference News NY Valves 2024 Essentials for 3D-ICE in Structural Interventions Explored in Position Statement Caitlin E. Cox June 06, 2024
News Conference News HRS 2024 LEADR: Small Diameter ICD Lead Meets Efficacy and Safety Thresholds L.A. McKeown May 27, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024